# Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection

> **NCT02482961** · — · COMPLETED · sponsor: **DongGuk University** · enrollment: 30 (actual)

## Conditions studied

- Acinetobacter Infections

## Interventions

- **DRUG:** colistimethate sodium

## Key facts

- **NCT ID:** NCT02482961
- **Lead sponsor:** DongGuk University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2018-01-10
- **Final completion:** 2018-04-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02482961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02482961, "Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02482961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*